Table 5.

Comparison of patients with SARS-CoV-2-induced rhabdomyolysis [13,14,15,16,17].

Authors	Chedid et al. [13]	Jin et al. [14]	Taxbro et al. [15]	Chetram et al. [16]	Solís et al. [17]
Patient characteristics	51-year-old man	60-year-old man	38-year-old man	62 year-old man	46-year-old man
Comorbidities	-hypertension -DM type 2 -OSA -CKD stage 2	no information	-DM type 2 -gout -mild obesity	-hypertension -obesity (BMI of 39.6) -DM type 2	-chronic myeloid leukemia
Symptoms	-diffuse myalgia (involving chest, back, arms and legs) -dry cough -mild chills	-cough -fever up to 38.3 °C -pain and weakness in the lower extremities (on the 9th day of hospitalization)	-fever -myalgia -nausea and vomiting -dry cough -breathlessness -abdominal pain	-general malaise -poor appetite -decreased urine output -haematuria -fever up to 38.1 °C	-cough -fever -dyspnea -generalized muscle pain
Laboratory abnormalities (peak levels):
Creatinine	19.09 mg/dL	74.4 µmol/L	278 µmol/L	>9, <10 mg/dL (value read from the graph)	16.25 mg/dL
LDH	>2150 U/L	2347 U/L	8.9 μkat/L	no information	26,967 U/L
CK	464,000 U/L	17,434 U/L	no information	327,629 U/L	426,700 U/L
Myoglobin	15,175 mg/L	12,550 µg/L	>21,000 μg/L	no information	no information
cTnT	708 ng/L	no information	444 ng/L	no information	no information
AST	1173 U/L	373 U/L	not reported	1077 U/L (no information if this is the peak value)	3565 U/L
Applied Renal Replacement Therapy	intermittent hemodialysis	-	CRRT-continuous venovenous haemodiafiltration	CRRT	CRRT- continuous veno-venous hemodiafiltration
Course/duration of hospitalization	discharged on day 15	no information	discharged after 23 days	discharged on day 26	died during hospitalization

DM, diabetes mellitus; OSA, obstructive sleep apnea; CKD, chronic kidney disease; CK, serum creatine kinase; LDH, lactate dehydrogenase; cTnT, troponin T; AST, aspartate aminotransferase; CRRT, continuous renal replacement therapy.